欧洲肝癌诊断市场预测至 2028 年 – COVID-19 影响和分析 – 按类型（实验室测试、内窥镜检查、成像、活检等）和最终用户（医院和诊断实验室、学术和研究机构等） CRO实验室）
No. of Pages: 137 | Report Code: BMIRE00025041 | Category: Life Sciences
No. of Pages: 137 | Report Code: BMIRE00025041 | Category: Life Sciences
肝细胞癌是最常见的肝癌类型。它始于主要类型的肝细胞（肝细胞），是最常见的原发性肝癌类型。肝细胞癌最常见于患有慢性肝病的人，例如乙型肝炎或丙型肝炎感染引起的肝硬化。其他类型的肝癌的发病率明显较低，例如肝内胆管癌和肝母细胞瘤。从身体其他部位（例如结肠、肺或乳腺癌）开始，然后扩散到肝脏的癌症称为转移性癌症。
此外，转移性结肠癌是一种从结肠开始并扩散到肝脏的癌症。例如，在欧洲，每年约有 47,000 人死于 HCC。除南欧外，该病的发病率相对较低，男性年龄标准化发病率为每10万人中9.8例，而北欧为3.8例，中欧和东欧为4.6例，西欧为7.2例。然而，在英国，2006 年至 2025 年间，HCC 死亡率预计将上升 14%，是男性癌症中增幅最大的。
<此外，超重或肥胖是肝癌的危险因素，非酒精性脂肪肝是肥胖人群的常见病症。患有非酒精性脂肪肝亚型（称为非酒精性脂肪性肝炎 (NASH)）的人可能会发展为肝硬化，从而导致肝癌。某些遗传性代谢疾病可导致肝硬化。生活方式和行为（例如吸烟和饮酒）是导致肝硬化的主要原因，而肝硬化又与肝癌风险增加有关。
2 型糖尿病与肝癌风险增加有关，通常发生在患有酗酒或慢性病毒性肝炎等其他危险因素的患者中。这种风险也可能会增加，因为 2 型糖尿病患者往往超重或肥胖，进而导致肝脏问题。根据 IDF 糖尿病图谱 2021 年第十版，目前约有 5.37 亿成年人（20-79 岁）患有糖尿病。预计到 2030 年，糖尿病患者总数将增至 6.43 亿，到 2045 年将增至 7.83 亿。上述因素正在增加肝癌的风险，从而推动肝癌诊断市场的发展。
借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动欧洲肝癌诊断市场实现大幅复合年增长率。
欧洲肝癌诊断市场细分
欧洲肝癌诊断根据类型、最终用户和国家/地区对市场进行分析。根据类型，市场分为实验室测试、成像、内窥镜检查、活检等。 2021年，实验室测试领域占据最大市场份额，成像领域预计在预测期内将实现更高的复合年增长率。
根据实验室测试，市场分为血液测试和生物标志物。 2021年，血液检测细分市场占有更大的市场份额，预计该细分市场在预测期内的复合年增长率最高。
< p>根据最终用户，市场分为医院和诊断实验室、学术和研究机构以及 CRO 实验室。 2021年，医院和诊断实验室细分市场占据最大市场份额，预计该细分市场在预测期内将实现更高的复合年增长率。
根据国家/地区，欧洲肝癌诊断市场分为德国、法国、英国、意大利、西班牙和欧洲其他地区。 2021年，德国占据最大的市场份额，英国预计在预测期内将以最快的复合年增长率增长。
雅培;生物梅里埃公司； F. 霍夫曼拉罗什有限公司；照明公司；皇家飞利浦公司；凯杰；西门子医疗股份公司；赛默飞世尔科技有限公司；通用电气医疗保健；和 Perspectum 是欧洲肝癌诊断市场的领先公司。
Strategic insights for Europe Liver Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2,567.59 Million |
| Market Size by 2028 | US$ 4,308.57 Million |
| Global CAGR (2021 - 2028) | 7.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Liver Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Liver Cancer Diagnostics Market is valued at US$ 2,567.59 Million in 2021, it is projected to reach US$ 4,308.57 Million by 2028.
As per our report Europe Liver Cancer Diagnostics Market, the market size is valued at US$ 2,567.59 Million in 2021, projecting it to reach US$ 4,308.57 Million by 2028. This translates to a CAGR of approximately 7.7% during the forecast period.
The Europe Liver Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Liver Cancer Diagnostics Market report:
The Europe Liver Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Liver Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Liver Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Liver Cancer Diagnostics Market
